Cargando…

Modified heptapeptide from tau binds both tubulin and microtubules

BACKGROUND: Microtubules are the major cytoskeletal component in eukaryotes which are essential for a large spectrum of cellular activities. Monitoring the behavior of microtubules is helpful for a better understanding of the regulatory mechanism governing microtubule architecture and microtubule‐ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jingrui, Li, Yuyang, Liu, Min, Xie, Songbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529580/
https://www.ncbi.nlm.nih.gov/pubmed/32893987
http://dx.doi.org/10.1111/1759-7714.13643
_version_ 1783589464058101760
author Li, Jingrui
Li, Yuyang
Liu, Min
Xie, Songbo
author_facet Li, Jingrui
Li, Yuyang
Liu, Min
Xie, Songbo
author_sort Li, Jingrui
collection PubMed
description BACKGROUND: Microtubules are the major cytoskeletal component in eukaryotes which are essential for a large spectrum of cellular activities. Monitoring the behavior of microtubules is helpful for a better understanding of the regulatory mechanism governing microtubule architecture and microtubule‐based activities. Here, we characterized the binding capability of a modified heptapeptide from tau to both tubulin and microtubules and sought to develop it as a fluorescent peptide for monitoring microtubules. METHODS: To deliver the fluorescent peptide into the cells, a cell‐penetrating peptide was conjugated to the modified heptapeptide from tau and synthesized. The affinity of the modified heptapeptide was determined by microscale thermophoresis. The microtubule labeling ability was determined by adding the peptide into the polymerized microtubule solutions or cultured HeLa cells.; RESULTS: Affinity determination revealed that the tau‐derived peptide specifically bound to tubulin. In addition, the peptide was able to label polymerized microtubules in solution, although no obvious microtubule filaments were observed clearly in living cells, probably due to the inadequate affinity. CONCLUSIONS: These results suggest that using a peptide‐based strategy for imaging microtubules might be plausible and attempts to improve its affinity is warranted in the future.
format Online
Article
Text
id pubmed-7529580
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley & Sons Australia, Ltd
record_format MEDLINE/PubMed
spelling pubmed-75295802020-10-05 Modified heptapeptide from tau binds both tubulin and microtubules Li, Jingrui Li, Yuyang Liu, Min Xie, Songbo Thorac Cancer Brief Reports BACKGROUND: Microtubules are the major cytoskeletal component in eukaryotes which are essential for a large spectrum of cellular activities. Monitoring the behavior of microtubules is helpful for a better understanding of the regulatory mechanism governing microtubule architecture and microtubule‐based activities. Here, we characterized the binding capability of a modified heptapeptide from tau to both tubulin and microtubules and sought to develop it as a fluorescent peptide for monitoring microtubules. METHODS: To deliver the fluorescent peptide into the cells, a cell‐penetrating peptide was conjugated to the modified heptapeptide from tau and synthesized. The affinity of the modified heptapeptide was determined by microscale thermophoresis. The microtubule labeling ability was determined by adding the peptide into the polymerized microtubule solutions or cultured HeLa cells.; RESULTS: Affinity determination revealed that the tau‐derived peptide specifically bound to tubulin. In addition, the peptide was able to label polymerized microtubules in solution, although no obvious microtubule filaments were observed clearly in living cells, probably due to the inadequate affinity. CONCLUSIONS: These results suggest that using a peptide‐based strategy for imaging microtubules might be plausible and attempts to improve its affinity is warranted in the future. John Wiley & Sons Australia, Ltd 2020-09-07 2020-10 /pmc/articles/PMC7529580/ /pubmed/32893987 http://dx.doi.org/10.1111/1759-7714.13643 Text en © 2020 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Reports
Li, Jingrui
Li, Yuyang
Liu, Min
Xie, Songbo
Modified heptapeptide from tau binds both tubulin and microtubules
title Modified heptapeptide from tau binds both tubulin and microtubules
title_full Modified heptapeptide from tau binds both tubulin and microtubules
title_fullStr Modified heptapeptide from tau binds both tubulin and microtubules
title_full_unstemmed Modified heptapeptide from tau binds both tubulin and microtubules
title_short Modified heptapeptide from tau binds both tubulin and microtubules
title_sort modified heptapeptide from tau binds both tubulin and microtubules
topic Brief Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529580/
https://www.ncbi.nlm.nih.gov/pubmed/32893987
http://dx.doi.org/10.1111/1759-7714.13643
work_keys_str_mv AT lijingrui modifiedheptapeptidefromtaubindsbothtubulinandmicrotubules
AT liyuyang modifiedheptapeptidefromtaubindsbothtubulinandmicrotubules
AT liumin modifiedheptapeptidefromtaubindsbothtubulinandmicrotubules
AT xiesongbo modifiedheptapeptidefromtaubindsbothtubulinandmicrotubules